| Document |
Document Title |
|
JP5047807B2 |
The present invention relates to a method for improving stability of non fluoridated sugar derivatives, and in particular glucose derivatives such as 1,3,4,6-tetra-O-acetyl-2-O-trifluoromethanesulfonyl-ß-D-man
nopyranose which are used ...
|
|
JP2012180328A |
To provide a new method for efficiently producing deoxyglucose modified at 6-position.This method for producing deoxyglucose modified at 6-position of formula (I) comprises: (i) a step of reacting polysaccharide curdlan with a halogenati...
|
|
JP5031376B2 |
The present invention relates to synthetic compounds that are active on plants, especially as legume nodulation factors, and also as plant growth stimulators, and to methods for preparing such compounds, which are of formula (I).
|
|
JP5029933B2 |
In the present application are disclosed a method for enhancing or improving the flavor of foods or drinks in general with the use of a non-volatile thiazolidine compound alone or a non-volatile flavor compound and/or a reaction flavor c...
|
|
JP5024585B2 |
|
|
JP5015903B2 |
To provide new diazeniumdiolates, (wherein the N1position is substituted by an inorganic or organic group and the O2-oxygen is bound to a substituted or unsubstituted aromatic group). The invention provided O2-glycosylated 1-substituted ...
|
|
JP5000521B2 |
The invention provides a method for the synthesis of an 18F-labelled product comprising deprotected of a protected 18F-labelled compound using a deprotection agent comprising a weak acid and wherein neutralisation and buffering of the de...
|
|
JP4981683B2 |
The present invention relates to a method for preparation of organofluoro compounds containing radioactive isotope fluorine-18. More particularly, the present invention relates to a method for preparation of primary or secondary organofl...
|
|
JP2012516305A |
2′-O-substituted 14- or 15-membered azalide macrolides of Formula (I) wherein R6 represents (i) —C1-8alkyl, unsubstituted or substituted at the terminal carbon atom by a group selected from hydroxy, —C1-3alkoxy and —C(O)OC1-3alky...
|
|
JP4979945B2 |
A process for producing a radioactive fluorine compound which comprises a step in which [18O] water containing [18F] fluoride ions is introduced into a column packed with an ion-exchange resin to collect the [18F] fluoride ions and a ste...
|
|
JP2012515721A |
Disclosed are certain complexes of AFC compounds and binding agents. Such complexes are useful, among other things, in the treatment of inflammatory diseases or disorders.
|
|
JP4959098B2 |
A 2-glucosamine derivative of the general formula (I):wherein R is an alkyl radical of the general formula CnH2n+1 and n is selected from 2-12; and pharmaceutically acceptable salts, esters and glucosides thereof, used for a treatment in...
|
|
JP4953499B2 |
To provide a printed wiring board which incorporates capacitors with which appropriate connection is provided. Chip capacitors 20 are housed in a core substrate 30. The chip capacitors 20 is electrically connected to first the second ele...
|
|
JP2012106933A |
To provide a compound which has high affinity to a double-stranded nucleic acid.The oligo-aminosaccharide compound formed by binding 3 to 6 saccharides, such as 2,6-diamino-2,6-dideoxy-α-(1→4)-D-glucopyranose oligomers, or a salt ther...
|
|
JP4926546B2 |
|
|
JP4916089B2 |
This invention relates to a method of obtaining sucralose from a feed mixture comprising 6-O-acyl-4,1',6'- trichloro-4,1',6'-trideoxygalactosucrose, other chlorinated sucrose byproducts, and optionally blocked or partially blocked chlori...
|
|
JPWO2010044371A1 |
Sweet receptor agonists such as Acesulfarm K, sucralose, saccharin or glycyrrhizin are used as active ingredients of insulin secretagogues. In addition, a test compound is added to cells expressing a sweet taste receptor, the sweet taste...
|
|
JP2012046511A |
To provide a polysulfated hyaluronic acid derivative useful for preventing and/or treating allergic diseases.A low molecular weight polysulfated hyaluronic acid derivative expressed by general formula (IA) or (IB) or a pharmaceutically a...
|
|
JP4889636B2 |
The present invention relates to the use of an organic glucosamine salt selected from glucosamine glucuronate, glucosamine ascorbate, glucosamine malate, glucosamine hydrogen malate, glucosamine citrate, glucosamine hydrogen citrate, and...
|
|
JP4884373B2 |
Disclosed is a novel monoclonal antibody 2A12 against dermatan sulfate An-DS derived from sea squirt (Ascidian nigra). A dermatan sulfate epitope having an iD-unit recognized by the antibody 2A12 is detected specifically in the hippocamp...
|
|
JP2012031107A |
To provide a method for efficiently producing a hetero disaccharide, which is expected to be a biologically active substance, from chitin, and its application; and also to provide a method of producing chitobiose and di-N-acetyl chitobio...
|
|
JP2012017303A |
To provide a method for controlling the outer diameter of a hollow fiber-shaped organic nanotube formed when using a β-D-glucopyranosylamine derivative composition comprising nonionic lipid molecules as a constitutional unit of the holl...
|
|
JP2012017306A |
To provide an industrial method for producing high-purity 2, 3, 4, 6-tetra-O-acyl-D-mannopyranosyl fluoride.In this method for producing 2, 3, 4, 6-tetra-O-acyl-D-mannopyranosyl fluoride by reacting 1, 2, 3, 4, 6-penta-O-acyl-D-mannopyra...
|
|
JP4847013B2 |
The invention relates to a manufacturing facility comprising a building structure which encloses working space of the manufacturing facility, the building structure being designed to house a cyclotron and to be transportable by truck or ...
|
|
JP4838706B2 |
Compounds that are adjuvants and immunoeffectors are described and claimed. The compounds augment antibody production in immunized animals as well as stimulate cytokine production and activate macrophages. Compositions and methods for us...
|
|
JP2011246481A |
To provide compositions used as adjuvants and immunoeffectors.There are provided certain aminoalkyl glucosaminide phosphate compounds (AGP) represented by formula (I), or pharmaceutically acceptable salts thereof.
|
|
JP4826824B2 |
|
|
JP4819240B2 |
|
|
JP2011225591A |
To provide crystalline sucralose that is a sweetener with sweetness intensity several hundred times compared to sucrose, and to provide a method for manufacturing the same.The method involves continuously crystallizing sucralose from an ...
|
|
JP2011528023A |
α-Lactosamine hydrochloride, substantially free of &bgr;-lactosamine hydrochloride; a method of preparing α-lactosamine hydrochloride monohydrate from an anomeric mixture of lactosamine hydrochloride, including: preparing a solution in...
|
|
JP4813741B2 |
|
|
JP4809763B2 |
A crystalline form of sucralose, and a method of making it. The method involves continuously crystallizing sucralose from an aqueous solution by a process providing continuous removal and recirculation of the vessel contents, and providi...
|
|
JP4787155B2 |
Methods and reagents for the formation of disulfide bonds, particularly in proteins, peptides and amino acids. The methods and reagents are particularly useful for the controlled glycosylation of proteins, peptides and amino acids. The m...
|
|
JP4782966B2 |
A phospholipid conjugate according to the general formula (I) or according to the general formula (II) for use in the treatment or prevention of a disorder selected from skin hypersensitivity, respiratory disease, eye disorder, and infla...
|
|
JP4771698B2 |
The system for making a swimming pool water retaining partition from prefabricated panels comprises a means (10) for the assembling of two consecutive vertical panels (1) and lower and upper belts supporting the panels. The assembly mean...
|
|
JP4731477B2 |
The invention relates to a compound of formula (I): wherein P1, P2, P3, and P4 are each independently hydrogen or a protecting group; and n is an integer of from 2 to 20 and to the use of such compounds for the synthesis of 18F-FDG.
|
|
JP4725976B2 |
The present invention is directed to a one-step process for the preparation of fructopyranose sulfamate derivatives of the general formula (I) wherein X, R1, R3, R4, R5 and R6 are as described in the specification.
|
|
JP4721571B2 |
|
|
JP4718765B2 |
|
|
JP4715513B2 |
An object of the present invention is to provide a method for efficiently chemically synthesizing biomolecules including a nucleotide (nucleic acid), a peptide (protein), or a sugar chain, as representative examples. The present inventio...
|
|
JP4713860B2 |
|
|
JP2011116725A |
To provide an anti-obesity agent and anti-obesity food and drink having anti-obesity action on both of body fat and body weight, effective for treatment and prevention of obesity and having excellent safety.The anti-obesity agent include...
|
|
JP4698773B2 |
The properties of biologically active compounds, for example drugs and agrochemicals, which contain in their molecular structure one or more functional groups selected from alcohol, ether, phenyl, amino, amido, thiol, carboxylic acid and...
|
|
JP4699373B2 |
Certain N-deacetylcolchicine and N-deacetylthiocolchine derivatives are described wherein the 7-N position on the B ring is substituted with the group - C(O)-(CHR 4 ) m -AR, wherein m is an integer of 0-10, A is S, O, N or a covalent bon...
|
|
JP2011516490T |
While the method of refining the water supply style containing Scralose extracts the water supply style containing a Scralose with the 1st organic solvent, The thing from which it is making the 1st organic extract and the 1st water extra...
|
|
JP2011516491T |
To the organic solvent for Scralose from the solution which contains Scralose, other chlorination sugars, sodium chloride, and dimethylannmonium chloride for Scralose at least, The process extracted by contacting the organic solvent in t...
|
|
JP2011515454T |
Like [which the present invention is the method of manufacturing Scralose from the supply style which contains a sucrose *6* reed rate in a reaction medium, and chlorinates at least about the 4th place of a (i) sucrose *6* reed rate, and...
|
|
JP2011093811A |
To provide an industrial method of producing sugar fluorinated at the anomeric position.A hexose pyranosyl fluoride protector, a pentose pyranosyl fluoride protector, a hexose franosyl fluoride protector or a pentose franosyl fluoride pr...
|
|
JP2011087589A |
To provide glycoconjugates, therapeutic compositions containing the glycoconjugates, and therapeutic methods of using the glycoconjugates.Peptide constituents of aglyco 10B are provided which are immunogenic epitopes responsible for reco...
|
|
JP2011079757A |
To provide a method for industrially simply producing a β-D-glucopyranosylamine long chain fatty acid derivative composition at a low cost.It has been found that the β-D-glucopyranosylamine long chain fatty acid derivative composition ...
|
